Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 40,110	$ 201,606
Accounts receivable, net	69,503	56,393
Inventories, net	145,736	144,609
Income taxes receivable	11,374	1,559
Current derivative financial instruments	22,578	38,298
Other current assets	19,460	17,464
Total current assets	308,761	459,929
Property, plant and equipment, net	329,892	398,599
Deferred income tax assets, net	39,046	52,213
Intangibles, net	12,612	33,242
Derivative financial instruments	14,736	40,471
Other noncurrent assets	35,082	46,117
Total assets	740,129	1,030,571
Current liabilities:
Accounts payable	120,351	124,907
Short-term debt	7,939	5,322
Accrued expenses	65,731	66,838
Income taxes payable	1,905	1,844
Total current liabilities	195,926	198,911
Long-term debt (less current portion)	481,449	610,632
Noncurrent income tax liabilities	5,341	8,129
Deferred income tax liabilities, net	1,105	1,903
Other noncurrent liabilities	43,581	47,821
Commitments and contingent liabilities (Note 17)
Mezzanine equity:
Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding - 150,000 shares outstanding at December 31, 2024 and December 31, 2023	288,465	248,222
Noncontrolling redeemable equity	480	893
Shareholders' equity deficit:
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding - 28,886,053 and 28,091,440 shares at December 31, 2024 and December 31, 2023	123,039	115,340
Accumulated other comprehensive income (loss)	(98,471)	(22,291)
Retained earnings (deficit)	(300,786)	(178,989)
Total shareholders' equity (deficit)	(276,218)	(85,940)
Total liabilities, mezzanine equity and shareholders' equity (deficit)	$ 740,129	$ 1,030,571